Promotional Features

Driving Active Nutrition Development
TSI Group

Paid for and content provided by TSI Group

The following content is provided by an advertiser or created on behalf of an advertiser. It is not written by the editorial team, nor does it necessarily reflect the opinions of

For more information, please contact us here​.

Driving Active Nutrition Development

Last updated on

Multi-tasking active adults are demanding healthy aging products that facilitate busy lifestyles and sustain robust health. Here’s how to choose a partner that fulfills those needs.

Across the world the concept of “sports nutrition” has evolved into “active nutrition” and this has further expanded to “lifestyle nutrition.” Throughout this evolution the consumer demand has increased with the ever-wider net that is cast by these category definitions. What is the next evolution of this category? For most of the world it is “healthy aging.”

According to the United Nations’ report, World Population Prospects 2019​, by 2050, 1 in 6 people in the world will be over the age of 65, a dramatic increase from 1 in 11 in 2019. All populations in the world are experiencing what the UN calls a “longevity revolution” to some degree. The percentage change from 2019 to 2050 in senior populations in Central and Southern Asia is 176%, while in Eastern and Southeastern Asia, that percentage is 120%.

The field for cultivating healthy aging products has never been more fertile: tablets that protect key joints (glucosamine and chondroitin), and sustained energy will dominate. Choosing your partner to produce these in-demand products is one of the most important decisions you will make.

Selecting a supplyside partner that has mastered the art of multi-tasking to supply the healthy aging ingredients with manufacturing and processing expertise and proven success in the US, Australia and in Europe will deliver that success for you in the marketplace.

Superior Tablets: Direct Compression Granules

Glucosamine (and chondroitin) are heavily preferred in tablet form by consumers on the go.

TSI owns a finished-dose contract manufacturing facility that has been producing approximately 400 unique formulations of glucosamine and glucosamine-chondroitin tablets.

The key to making an excellent mobility-support tablet with glucosamine is using a granule with the desired compressibility – not just a specified particle size distribution (PSD). TSI, with joint expertise in raw material supply and tablet manufacturing, measures the compressibility of every batch to make sure manufacturers can compress the best tablet (not just to deliver on PSD as per spec requirements).

Better granules ensure your tableting process runs much more smoothly without stoppages to adjust for varying PSD batches. This saves you precious time and money.

Further, DC granules enables production of smaller tablets with better hardness, uniformity and disintegration time, and without chipping and capping, as well as improves tablet aesthetics, improves operational efficiency and reduces overall costs.

The right (high compressibility) granule is the basis of a tablet that performs as the consumer expects and desires.

Triple Play for Healthy Active Aging

The healthy aging consumer today realises that the ability to maintain activity is essential to prolonging a good and desirable quality of life. To customize your formulas TSI has unique ingredients that resonate with active lifestylers and multi-taskers who pack as much family, fun, work and experience as they can into every day. Joint protection, quicker recovery and sustained energy comprise the triad of wellness-fueled empowerment for healthy aging.  And these goals are what consumers want.

For joint health, GlucosaGreen®​ is a clean label-friendly glucosamine manufactured via a patent-protected process that uses a unique fermentation technology on non-GMO corn to produce glucosamine bioequivalent to shellfish glucosamine. And this process is much more suitable to the well-being of the environment.

Compared to glucosamine obtained from shellfish, GlucosaGreen fulfills vegan and vegetarian needs, as well as leaves dramatically reduced waste from production: GlucosaGreen produces only 2% of the waste compared to shellfish glucosamine. It takes only 2 MTs of clean water to produce the same amount of glucosamine – 99.9 per cent less water than required for shellfish-derived glucosamine. GlucosaGreen is available for manufacture in a variety of forms, including its exclusive DC granules used to make premium tablets via direct compression.

TSI’s PEAK ATP®​, a patented form of adenosine 5’-triphosphate, acts as a primary source of energy and also improves recovery. TSI’s myHMB®​ is a prolifically researched and branded beta-hydroxy beta-methylbutyrate (HMB) that works via a dual mechanism that builds muscle mass and strength while preserving muscle as one ages.

The recent acquisition of Metabolic Technologies -- the originator of HMB -- underscores TSI’s expertise in and commitment to fulfilling desires for natural, safe, efficacious and sustainable healthy aging ingredients that enhance quality of life throughout life.

More content from TSI Group

show more